Genomma Lab Internacional SAB de CV
http://www.genommalab.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Genomma Lab Internacional SAB de CV
Genomma Enjoys Strong Q2 Thanks To Big Gains in US
Mexico's Genomma Lab recorded strong double-digit growth for its OTC business in the second quarter as sales more than doubled at its US consumer health operation.
Consumer Health Results Roundup: Genomma, Ipsen And Taisho
Mexico's Genomma enjoys good growth in the second quarter, while Japan's Taisho records a steady start to its new financial year. Meanwhile, France's Ipsen endures a difficult period as its biggest OTC brand falters.
LATAM OTC Results Round-Up: Mexico's Genomma Lab, Brazil's Hypera
Genomma enjoys broad-based growth in 2018, while NPD investments pay off for Hypera.
Silka Marketer Scratches Monograph Claim Itch In NAD Review
In response to a National Advertising Division inquiry on efficacy claims challenged by Bayer Healthcare, the US subsidiary of Mexican firm Genomma Lab Corp. said some claims for its Silka athlete's foot treatment were discontinued "but continued to air due to a miscommunication in its marketing department."
Company Information
- Industry
-
Pharmaceuticals
- OTC, Consumer